MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients - Related Studies

MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

This study has been completed.

Study NCT00082537. Last updated on May 13, 2008. Information provided by Merck

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neutropenia
		Fever

2	More general conditions related to this trial
		Agranulocytosis
		Hematologic Diseases
		Leukocyte Disorders
		Leukopenia

3	Interventions listed in this trial
		caspofungin acetate
		Comparator: AmBisome

4	Additional drug interventions recognized in this trial
		Amphotericin B
		Caspofungin

5	More general drug interventions related to this trial
		Amebicides
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antifungal Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Merck